Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Leukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J CastilloBritish Journal of Haematology|April 25, 2018
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomasAdam J Olszewski, Thomas Ollila, John L ReaganBone Marrow Transplantation|November 13, 2024
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemiaMary R Christopher, Mariam T Nawas, John L ReaganClinical Neurology and Neurosurgery|September 16, 2020
Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosisAndrew Hsu, Hetal Mistry, Nupur Lala, et al.Rhode Island Medical Journal (2013)|July 26, 2022
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient ManagementArun Muthiah, Sarah Ohnigian, John L Reagan, et al.Cancer Medicine|October 1, 2019
Use of bone-modifying agents and clinical outcomes in older adults with multiple myelomaAdam J Olszewski, Peter M Barth, John L ReaganClinical Lymphoma, Myeloma & Leukemia|January 24, 2018
Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective ReviewRory M Shallis, Rachel S Rome, John L ReaganLeukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J OlszewskiAmerican Journal of Hematology|September 12, 2020
Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myelomaPeter Barth, Smith Giri, John L Reagan, et al.Experimental Hematology & Oncology|October 17, 2018
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cellsAlejandro Pando, John L Reagan, Martha Nevola, et al.Pageof 7